{"nct_id":"NCT03770299","title":"An Investigational Immuno-therapy Study of Nivolumab Given After Surgery in Non-Small Cell Lung Cancer (NSCLC) Participants With Minimal Residual Disease","status":"WITHDRAWN","status_verified_date":"2022-03","start_date":"2021-01-15","start_date_type":"ESTIMATED","primary_completion_date":"2023-03-14","primary_completion_date_type":"ESTIMATED","completion_date":"2024-03-14","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["BMY"]}